You just read:

Norgine: New Real World Study Shows Rifaximin-a Significantly Reduced Hospitalisation in Patients With Overt Hepatic Encephalopathy (HE) When Added to Lactulose

News provided by

Norgine

15 Apr, 2019, 09:00 BST